Total Payments
$700.52
2024 Payments
$36.79
Companies
5
Transactions
26
Medicare Patients
8,371
Medicare Billing
$950,166
Payment Breakdown by Category
Education$383.70 (54.8%)
Food & Beverage$316.82 (45.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $383.70 | 7 | 54.8% |
| Food and Beverage | $316.82 | 19 | 45.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $459.64 | 6 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $175.36 | 16 | $0 (2024) |
| PFIZER INC. | $26.13 | 2 | $0 (2019) |
| Verity Pharmaceuticals Inc. | $23.06 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $16.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.79 | 2 | Verity Pharmaceuticals Inc. ($23.06) |
| 2023 | $320.33 | 17 | Sumitomo Pharma America, Inc. ($161.63) |
| 2019 | $104.56 | 3 | Astellas Pharma US Inc ($78.43) |
| 2018 | $147.52 | 2 | Astellas Pharma US Inc ($147.52) |
| 2017 | $91.32 | 2 | Astellas Pharma US Inc ($74.99) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: Prostate cancer | ||||||
| 07/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: UROLOGY | ||||||
| 11/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Urology | ||||||
| 10/31/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Urology | ||||||
| 10/05/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Urology | ||||||
| 09/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Urology | ||||||
| 08/15/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Urology | ||||||
| 07/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Urology | ||||||
| 06/23/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Urology | ||||||
| 05/23/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Urology | ||||||
| 04/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Urology | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Urology | ||||||
| 03/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Urology | ||||||
| 02/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Urology | ||||||
| 01/26/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 01/26/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Urology | ||||||
| 01/06/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Urology | ||||||
| 01/05/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.35 | General |
| 01/05/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.35 | General |
| 11/06/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $78.43 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $11.50 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 09/15/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $47.57 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,760 | 2,353 | $629,958 | $197,130 |
| 2022 | 26 | 1,968 | 28,504 | $711,111 | $221,058 |
| 2021 | 25 | 2,096 | 2,743 | $726,072 | $234,125 |
| 2020 | 34 | 2,547 | 41,612 | $968,418 | $297,853 |
Total Patients
8,371
Total Services
75,212
Medicare Billing
$950,166
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 699 | 800 | $120,800 | $45,598 | 37.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 110 | 136 | $56,712 | $22,705 | 40.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 41 | 49 | $73,990 | $22,338 | 30.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 147 | $74,529 | $19,542 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $47,196 | $14,963 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 177 | $39,294 | $14,849 | 37.8% |
| 52317 | Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm | Facility | 2023 | 24 | 30 | $48,750 | $7,480 | 15.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 70 | 90 | $30,420 | $7,273 | 23.9% |
| 52352 | Removal or manipulation of stone in ureter or kidney using an endoscope | Facility | 2023 | 27 | 30 | $23,160 | $7,271 | 31.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 89 | 89 | $19,847 | $6,996 | 35.3% |
| 51705 | Simple change of bladder tube | Office | 2023 | 16 | 89 | $22,695 | $5,972 | 26.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 13 | 14 | $12,698 | $4,400 | 34.6% |
| 52330 | Manipulation of stone in ureter using an endoscope | Facility | 2023 | 14 | 14 | $14,112 | $2,888 | 20.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 38 | 50 | $9,250 | $2,773 | 30.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 11 | 11 | $3,630 | $2,617 | 72.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 32 | $5,152 | $1,761 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 172 | $5,332 | $1,678 | 31.5% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 12 | 12 | $3,696 | $1,226 | 33.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,444 | $1,203 | 34.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 49 | $4,067 | $1,066 | 26.2% |
| 51703 | Complicated insertion of bladder tube | Facility | 2023 | 12 | 16 | $4,224 | $933.28 | 22.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 116 | 121 | $4,477 | $844.32 | 18.9% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 11 | 11 | $2,079 | $614.24 | 29.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 48 | 53 | $371.00 | $115.30 | 31.1% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 11 | 11 | $33.00 | $24.24 | 73.5% |
About Dr. Michael Peaster, M.D
Dr. Michael Peaster, M.D is a Urology healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437137288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Peaster, M.D has received a total of $700.52 in payments from pharmaceutical and medical device companies, with $36.79 received in 2024. These payments were reported across 26 transactions from 5 companies. The most common payment nature is "Education" ($383.70).
As a Medicare-enrolled provider, Peaster has provided services to 8,371 Medicare beneficiaries, totaling 75,212 services with total Medicare billing of $950,166. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Bartlesville, OK
- Active Since 01/03/2006
- Last Updated 01/06/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1437137288
Products in Payments
- XTANDI (Drug) $152.13
- GEMTESA (Drug) $151.43
- ORGOVYX (Drug) $23.93
- Trelstar (Drug) $23.06
- INTERSTIM (Device) $16.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.